Furthermore, even in the early stages, breast cancer patients have increased serum levels of prostaglandin E2 (PGE2) [8] and proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β and IL-6 [9]. This evidence concerns the gene TNF and breast carcinoma.